Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 486	$ 393
Restricted cash and cash equivalents	31	29
Default funds and margin deposits (including restricted cash and cash equivalents of $5,398 and $5,074, respectively)	6,570	5,911
Financial investments	225	208
Receivables, net	621	588
Other current assets	245	294
Total current assets	8,178	7,423
Property and equipment, net	511	509
Goodwill	8,338	8,433
Intangible assets, net	2,751	2,813
Operating lease assets	470	366
Other non-current assets	575	571
Total assets	20,823	20,115
Current liabilities:
Accounts payable and accrued expenses	186	185
Section 31 fees payable to SEC	53	62
Accrued personnel costs	168	252
Deferred revenue	619	329
Other current liabilities	157	115
Default funds and margin deposits	6,570	5,911
Short-term debt	1,098	1,018
Total current liabilities	8,851	7,872
Long-term debt	4,800	4,812
Deferred tax liabilities, net	431	406
Operating lease liabilities	478	386
Other non-current liabilities	241	234
Total liabilities	14,801	13,710
Commitments and contingencies
Nasdaq stockholders’ equity:
Common stock, $0.01 par value, 300,000,000 shares authorized, shares issued: 171,535,457 at March 31, 2022 and 173,418,939 at December 31, 2021; shares outstanding: 164,488,485 at March 31, 2022 and 166,679,635 at December 31, 2021	2	2
Additional paid-in capital	1,510	1,952
Common stock in treasury, at cost: 7,046,972 shares at March 31, 2022 and 6,739,304 shares at December 31, 2021	(489)	(437)
Accumulated other comprehensive loss	(1,670)	(1,587)
Retained earnings	6,660	6,465
Total Nasdaq stockholders’ equity	6,013	6,395
Noncontrolling interests	9	10
Total equity	6,022	6,405
Total liabilities and equity	$ 20,823	$ 20,115